Eton Pharmaceuticals Submits New Drug Application for Desmopressin Oral Solution

Deer Park, Monday, 28 April 2025.
Eton Pharmaceuticals submits an NDA for Desmopressin Oral Solution, potentially making it the only FDA-approved oral liquid for central diabetes insipidus in children, pending a 10-month review.